| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |